Evidence map›Paper›PMID 37368300›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Dual Labeling of Primary Cells with Fluorescent Gadolinium Oxide Nanoparticles.

Nadine Brune, Benedikt Mues, Eva Miriam Buhl, Kai-Wolfgang Hintzen, Stefan Jockenhoevel, Christian G Cornelissen, Ioana Slabu, Anja Lena Thiebes

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nadine BruneInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-5311-4592
Benedikt MuesInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-3697-5032
Eva Miriam BuhlInstitute of Pathology, Electron Microscopy Facility, University Clinic Aachen, 52074 Aachen, Germany.
Kai-Wolfgang HintzenInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Stefan JockenhoevelInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0003-0584-9444
Christian G CornelissenInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
Ioana SlabuInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-8945-4310
Anja Lena ThiebesInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-2990-0761

Funding

Deutsche Forschungsgemeinschaft 394605884Deutsche Forschungsgemeinschaft 467959793
6 · The paper itself

Abstract

The interest in mesenchymal stromal cells as a therapy option is increasing rapidly. To improve their implementation, location, and distribution, the properties of these must be investigated. Therefore, cells can be labeled with nanoparticles as a dual contrast agent for fluorescence and magnetic resonance imaging (MRI). In this study, a more efficient protocol for an easy synthesis of rose bengal-dextran-coated gadolinium oxide (Gd

Indexed as

adipose-derived mesenchymal stromal cells (ASC)contrast agentdextranmagnetic resonance imaging (MRI)rose bengal

Identifiers

PMID37368300
PMCPMC10304197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.